Staying on the GLP-1 meds particularly helped the nearly 17% of patients who had prediabetes, a condition in which elevated blood sugar levels increase a person's risk of developing Type 2 diabetes
Obesity and depression: its prevalence and influence as a prognostic factor: a systematic review
Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease
And it establishes the habit and discipline of defined eating windows before moving to more restrictive protocols
Patients must be clearly informed of the risks associated with nonFDA-approved products, including potential contamination, inaccurate dosing, variable bioactivity, and the presence of impurities that may provoke adverse or unpredictable effects
It doesnt stop there, though
![Pokémon TCG JP: Ruler of the Black Flame [SV3] Booster Box – Tofu's Trading](https://tofustrading.com/cdn/shop/files/ShopifyInventory_23_bde18138-9da3-4231-9e41-d8116a46245f.png?v=1714781286&width=1080)
